Who is eligible for clinical trial NCT05306743?

Participants must meet protocol criteria for Chronic Obstructive Pulmonary Disease. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT05306743 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2023-10-11

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD. (NCT05306743)

🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Observational and Pragmatic Research Institute

🩺 Plain-English Summary (8th-Grade Level)

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (3 items).

Location: University of Colorado — Denver, Colorado

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Primary Care Teams (PCTs) must be able to function as a single randomization unit with low risk of contamination between participants and physicians due to the absence of blinding in the intervention (see section 8.8 for details on blinding).
PCT must have a sufficient number of patients meeting modifiable high-risk patient criteria (see section 8.1 on sample size estimates).
PCT must express willingness to be randomized to either receive the CONQUEST program initially, or usual care until program roll-out to the delayed intervention arm.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
PCTs that are in the process of, or planning to change EHR software provider or practice ownership within the trial outcome evaluation period
PCTs engaged in active research studies or COPD related Quality Improvement Programs which might impact the ability to implement CONQUEST program.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (3 Sites)

University of Colorado — Denver, Colorado
Mount Sinai — New York, New York
MetroHealth — Cleveland, Ohio

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗